Clinical orthopaedics and related research · 2009
Inferior survival of hydroxyapatite versus titanium-coated cups at 15 years.
Сравнительное исследованиеСтатьяРандомизированное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Stilling Maiken, Rahbek Ole, Søballe Kjeld
Аннотация
UNLABELLED: Hydroxyapatite (HA) particles have long been suspected to disintegrate from implant surfaces, become entrapped in joint spaces of orthopaedic bearing couples, and start a cascade leading to progressive polyethylene (PE) wear, increased osteolysis, and aseptic loosening. We compared cup revision at 15 years' followup in a randomized group of patients with 26 cementless THA components with titanium (Ti) versus first-generation HA coating. We also assessed radiographic PE wear and osteolysis to the 12-year followup or end point revision at a minimum of 5 years (mean, 10.9 years; range, 5-12.6 years). Two Ti-coated cups (17%) and eight HA-coated cups (57%) were revised at 15 years' followup. Femoral head penetration rate was 0.46 mm/year (standard deviation, 0.26) with the HA-coated cups (n = 12) and 0.38 mm/year (standard deviation, 0.14) with the Ti-coated cups (n = 10); we observed a wide variance of linear wear with the HA-coated cups. We also observed a positive association between high wear rate and revision, and between a high volume of osteolysis and revision. Our findings suggest inferior survival of medium-thickness spray-dried HA-coated cups with individual cases of excessive PE wear and premature cup failure. These findings apply to first-generation modular cups and may not apply to other cup designs and new HA-coating technologies.
LEVEL OF EVIDENCE: Level III, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.
LEVEL OF EVIDENCE: Level III, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.
Предметные рубрики MeSH
AgedArthroplasty, Replacement, HipCoated Materials, BiocompatibleDurapatiteEquipment SafetyFemaleFollow-Up StudiesHip ProsthesisHumansJoint InstabilityKaplan-Meier EstimateMaleMaterials TestingMiddle AgedOsteoarthritis, HipOsteolysisProbabilityProspective StudiesProsthesis DesignProsthesis FailureRisk AssessmentStatistics, NonparametricTime FactorsTitaniumTreatment Outcome